Company Analysis

Karyopharm Therapeutics Inc. (KPTI)

Nasdaq: KPTI · Pharmaceutical Preparations · Newton, MA · filing with the SEC since 2010
Grade3.8
◀ Past 3.7● Present 3.6▶ Future 4.3
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 13, 2026Feb 19, 2025Feb 29, 2024Feb 17, 2023Mar 1, 2022Feb 24, 2021Feb 26, 2020Feb 28, 2019Mar 15, 2018Mar 16, 2017
Revenue146,067145,237146,033157,074209,819108,08540,89330,3361,605154
Research and development125,617143,232138,750148,662160,842150,813122,340161,372107,27386,938
Selling, general and administrative105,208115,441131,881145,401143,846126,417105,42148,84724,870·
General and administrative·······48,84724,87023,948
Total operating expenses236,774264,680275,573299,276308,090279,935230,168210,219132,143110,886
Total costs and expenses····3,4022,7052,407···
Operating income-90,707-119,443-129,540-142,202-98,271-171,850-189,275-179,883-130,538-110,732
Interest expense45,84937,42223,82324,99626,04627,14015,6472,493··
Interest and investment income2,7737,40010,9432,3595822,8205,4224,0281,6981,284
Other income (expense), net15228,398-356-83-85206-50-33-8110
Total non-operating income (expense)-105,28943,078-13,236-22,720-25,549-24,114-10,2751,5021,6171,294
Income before income taxes-195,996-76,365-142,776-164,922-123,820-195,964-199,550-178,381-128,921-109,438
Income tax expense4357323369268309402663139
Net income including non-controlling interests-196,039-76,422-143,099-165,291-124,088-196,273-199,590-178,407-128,984-109,577
Net income-196,039-76,422-143,099-165,291-124,088-196,273-199,590-178,407-128,984-109,577
Earnings per share, basic-17.93-9.41r-18.79r-30.30b-24.75b-40.80b····
Earnings per share, diluted-17.93-14.00r-18.79r-30.30b-24.75b-40.80b····
Earnings per share, basic and diluted····-24.75b-40.80b-48.30b-47.10b-42.15b-43.80b
Weighted average shares, basic10,9358,125r7,616r5,458rb5,014,533b4,802,933b····
Weighted average shares, diluted10,935,000b8,455,000rb7,616,000rb5,458,000rb5,014,533b4,802,933b····
Weighted average shares, basic and diluted····5,014,533b4,802,933rb4,130,333rb3,785rb3,059,986b2,501,537b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton KPTI · research, not advice